company background image
2159

Mediwelcome Healthcare Management & Technology SEHK:2159 Stock Report

Last Price

HK$1.17

Market Cap

HK$234.0m

7D

2.6%

1Y

-46.8%

Updated

24 Jun, 2022

Data

Company Financials
2159 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

2159 Stock Overview

Mediwelcome Healthcare Management & Technology Inc., an investment holding company, provides integrated healthcare marketing solutions in the People’s Republic of China.

Mediwelcome Healthcare Management & Technology Competitors

 

 

 

 

 

 

 

 

 

 

 

 

Price History & Performance

Summary of all time highs, changes and price drops for Mediwelcome Healthcare Management & Technology
Historical stock prices
Current Share PriceHK$1.17
52 Week HighHK$2.28
52 Week LowHK$0.83
Beta0
1 Month Change0.86%
3 Month Change11.43%
1 Year Change-46.82%
3 Year Changen/a
5 Year Changen/a
Change since IPO-69.13%

Recent News & Updates

Apr 08
Calculating The Intrinsic Value Of Mediwelcome Healthcare Management & Technology Inc. (HKG:2159)

Calculating The Intrinsic Value Of Mediwelcome Healthcare Management & Technology Inc. (HKG:2159)

Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Mediwelcome Healthcare...

Jan 24
Some Investors May Be Worried About Mediwelcome Healthcare Management & Technology's (HKG:2159) Returns On Capital

Some Investors May Be Worried About Mediwelcome Healthcare Management & Technology's (HKG:2159) Returns On Capital

What are the early trends we should look for to identify a stock that could multiply in value over the long term...

Shareholder Returns

2159HK HealthcareHK Market
7D2.6%6.7%1.2%
1Y-46.8%-68.4%-23.3%

Return vs Industry: 2159 exceeded the Hong Kong Healthcare industry which returned -68.4% over the past year.

Return vs Market: 2159 underperformed the Hong Kong Market which returned -23.3% over the past year.

Price Volatility

Is 2159's price volatile compared to industry and market?
2159 volatility
2159 Average Weekly Movement9.1%
Healthcare Industry Average Movement8.3%
Market Average Movement7.0%
10% most volatile stocks in HK Market13.7%
10% least volatile stocks in HK Market3.3%

Stable Share Price: 2159 is not significantly more volatile than the rest of Hong Kong stocks over the past 3 months, typically moving +/- 9% a week.

Volatility Over Time: 2159's weekly volatility (9%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2000408Liang Wanghttps://www.mediwelcome.com

Mediwelcome Healthcare Management & Technology Inc., an investment holding company, provides integrated healthcare marketing solutions in the People’s Republic of China. It offers medical conference, patient education and screening, and marketing strategy and consulting services; and contract research organization services consist of patient’s recruitment and clinical data collection services. The company also operates a mobile application to provide internet hospital services comprising online follow up consultation to the physicians’ existing patients and e-prescription services.

Mediwelcome Healthcare Management & Technology Fundamentals Summary

How do Mediwelcome Healthcare Management & Technology's earnings and revenue compare to its market cap?
2159 fundamental statistics
Market CapCN¥199.67m
Earnings (TTM)CN¥4.65m
Revenue (TTM)CN¥708.36m

43.0x

P/E Ratio

0.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
2159 income statement (TTM)
RevenueCN¥708.36m
Cost of RevenueCN¥614.76m
Gross ProfitCN¥93.60m
Other ExpensesCN¥88.95m
EarningsCN¥4.65m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)0.023
Gross Margin13.21%
Net Profit Margin0.66%
Debt/Equity Ratio0%

How did 2159 perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.

Valuation

Is 2159 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • PEG Ratio

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 2159?

Other financial metrics that can be useful for relative valuation.

2159 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue0.08x
Enterprise Value/EBITDA4.8x
PEG Ration/a

Price to Earnings Ratio vs Peers

How does 2159's PE Ratio compare to its peers?

2159 PE Ratio vs Peers
The above table shows the PE ratio for 2159 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average11.1x

Price-To-Earnings vs Peers: 2159 is expensive based on its Price-To-Earnings Ratio (43x) compared to the peer average (11.1x).


Price to Earnings Ratio vs Industry

How does 2159's PE Ratio compare vs other companies in the Hong Kong Healthcare Industry?

Price-To-Earnings vs Industry: 2159 is expensive based on its Price-To-Earnings Ratio (43x) compared to the Hong Kong Healthcare industry average (17.3x)


Price to Earnings Ratio vs Fair Ratio

What is 2159's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

2159 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio43x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 2159's Price-To-Earnings Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of 2159 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 2159's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 2159's fair value for valuation analysis.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 2159's PEG Ratio to determine if it is good value.


Discover undervalued companies

Future Growth

How is Mediwelcome Healthcare Management & Technology forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


28.6%

Forecasted Healthcare industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Mediwelcome Healthcare Management & Technology has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Discover growth companies

Past Performance

How has Mediwelcome Healthcare Management & Technology performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


-41.7%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 2159 has a high level of non-cash earnings.

Growing Profit Margin: 2159's current net profit margins (0.7%) are lower than last year (4.9%).


Past Earnings Growth Analysis

Earnings Trend: 2159's earnings have declined by 41.7% per year over the past 5 years.

Accelerating Growth: 2159's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 2159 had negative earnings growth (-77.9%) over the past year, making it difficult to compare to the Healthcare industry average (34.8%).


Return on Equity

High ROE: 2159's Return on Equity (1.8%) is considered low.


Discover strong past performing companies

Financial Health

How is Mediwelcome Healthcare Management & Technology's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: 2159's short term assets (CN¥275.3M) exceed its short term liabilities (CN¥57.3M).

Long Term Liabilities: 2159's short term assets (CN¥275.3M) exceed its long term liabilities (CN¥15.9M).


Debt to Equity History and Analysis

Debt Level: 2159 is debt free.

Reducing Debt: 2159 has not had any debt for past 5 years.

Debt Coverage: 2159 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 2159 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Dividend

What is Mediwelcome Healthcare Management & Technology current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate 2159's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate 2159's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if 2159's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 2159's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as 2159 has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

2.8yrs

Average management tenure


CEO

Liang Wang (46 yo)

no data

Tenure

Mr. Liang Wang serves as the Chief Executive Officer at Mediwelcome Healthcare Management & Technology Inc. and has been its Executive Director since September 18, 2019. Mr. Wang co-founded Mediwelcome Gro...


Leadership Team

Experienced Management: 2159's management team is considered experienced (2.8 years average tenure).


Board Members

Experienced Board: 2159's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Mediwelcome Healthcare Management & Technology Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Mediwelcome Healthcare Management & Technology Inc.
  • Ticker: 2159
  • Exchange: SEHK
  • Founded: 2000
  • Industry: Health Care Services
  • Sector: Healthcare
  • Implied Market Cap: HK$234.000m
  • Shares outstanding: 200.00m
  • Website: https://www.mediwelcome.com

Number of Employees


Location

  • Mediwelcome Healthcare Management & Technology Inc.
  • Parkview Place
  • 10th-12th Floor
  • Beijing
  • China

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/06/24 00:00
End of Day Share Price2022/06/24 00:00
Earnings2021/12/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.